
AngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2024 Update
Description
AngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2024 Update
Summary
AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimal invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. The company’s products find application in interventional radiology, interventional cardiology, and minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. It sells its products through direct sales force in the US and through a network of distributors outside the US, which include Latin America Europe, Asia, and others. AngioDynamics is headquartered in Latham, New York, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company AngioDynamics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
93 Pages
- AngioDynamics Inc Company Overview
- AngioDynamics Inc Company Snapshot
- AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
- AngioDynamics Inc – Pipeline Analysis Overview
- Business Description
- AngioDynamics Inc - Key Facts
- AngioDynamics Inc - Major Products and Services
- AngioDynamics Inc Pipeline Products by Development Stage
- AngioDynamics Inc Ongoing Clinical Trials by Trial Status
- AngioDynamics Inc Pipeline Products Overview
- Acuswift
- Acuswift Product Overview
- Alphavac F13 10
- Alphavac F13 10 Product Overview
- Alphavac F14 20
- Alphavac F14 20 Product Overview
- Alphavac System - Infective Endocarditis
- Alphavac System - Infective Endocarditis Product Overview
- Alphavac System - Left Atrial Appendage Thrombus
- Alphavac System - Left Atrial Appendage Thrombus Product Overview
- AngioVac - Generation 4
- AngioVac - Generation 4 Product Overview
- AngioVac - Left Heart
- AngioVac - Left Heart Product Overview
- AngioVac Low Profile Catheter
- AngioVac Low Profile Catheter Product Overview
- AURYON Atherectomy System - CAD
- AURYON Atherectomy System - CAD Product Overview
- AURYON Atherectomy System - Gastrointestinal Procedures
- AURYON Atherectomy System - Gastrointestinal Procedures Product Overview
- AURYON Atherectomy System - Iliofemoral DVT
- AURYON Atherectomy System - Iliofemoral DVT Product Overview
- AURYON Atherectomy System - Lead Extraction
- AURYON Atherectomy System - Lead Extraction Product Overview
- AURYON Atherectomy System - Venous Disease
- AURYON Atherectomy System - Venous Disease Product Overview
- AURYON System - Small Vessel Thrombectomy
- AURYON System - Small Vessel Thrombectomy Product Overview
- Automated Fluid Management System
- Automated Fluid Management System Product Overview
- BioFlo PICC Line Extension
- BioFlo PICC Line Extension Product Overview
- BioFlo Portline Line Extension
- BioFlo Portline Line Extension Product Overview
- Coronary Angio Catheter
- Coronary Angio Catheter Product Overview
- FireFly Tip Location
- FireFly Tip Location Product Overview
- Inflation Device
- Inflation Device Product Overview
- Mechanical Thrombectomy Device
- Mechanical Thrombectomy Device Product Overview
- Multi-Purpose Mechanical Aspiration - F1885 PE
- Multi-Purpose Mechanical Aspiration - F1885 PE Product Overview
- Multi-Purpose Mechanical Aspiration Gen 2
- Multi-Purpose Mechanical Aspiration Gen 2 Product Overview
- NanoKnife 3.0 System - Liver Cancer
- NanoKnife 3.0 System - Liver Cancer Product Overview
- NanoKnife 3.0 System - Pancreatic Cancer
- NanoKnife 3.0 System - Pancreatic Cancer Product Overview
- NanoKnife 3.0 System - Prostate Cancer
- NanoKnife 3.0 System - Prostate Cancer Product Overview
- Nanoknife System - Bladder Cancer
- Nanoknife System - Bladder Cancer Product Overview
- NanoKnife System - Cervical Cancer
- NanoKnife System - Cervical Cancer Product Overview
- NanoKnife System - Head And Neck Cancer
- NanoKnife System - Head And Neck Cancer Product Overview
- NanoKnife System - Hepatocellular Carcinoma
- NanoKnife System - Hepatocellular Carcinoma Product Overview
- NanoKnife System - Lung Cancer
- NanoKnife System - Lung Cancer Product Overview
- NanoKnife System - Lung Cancer Clinical Trial
- Nanoknife System - Metastatic Lymph Nodes
- Nanoknife System - Metastatic Lymph Nodes Product Overview
- NanoKnife System - Prostate Cancer
- NanoKnife System - Prostate Cancer Product Overview
- NanoKnife System - Prostate Cancer Clinical Trial
- NanoKnife System - Rectal Cancer
- NanoKnife System - Rectal Cancer Product Overview
- Nanoknife System - Renal Pelvis Urothelial Neoplasms
- Nanoknife System - Renal Pelvis Urothelial Neoplasms Product Overview
- NanoKnife System - Stage III Pancreatic Cancer
- NanoKnife System - Stage III Pancreatic Cancer Product Overview
- NanoKnife System - Stage III Pancreatic Cancer Clinical Trial
- Nanoknife System - Stomach Neoplasm
- Nanoknife System - Stomach Neoplasm Product Overview
- Next Gen Tumescent Delivery Device
- Next Gen Tumescent Delivery Device Product Overview
- Next Generation BioFlo PICC
- Next Generation BioFlo PICC Product Overview
- Next Generation BioFlo Port
- Next Generation BioFlo Port Product Overview
- Next Generation Dialysis Device
- Next Generation Dialysis Device Product Overview
- Next Generation Laser
- Next Generation Laser Product Overview
- Next Generation Radio Frequency Ablation System
- Next Generation Radio Frequency Ablation System Product Overview
- Non-Thermal Vein Ablation Device
- Non-Thermal Vein Ablation Device Product Overview
- Peripheral Vascular Drainage Line Extension
- Peripheral Vascular Drainage Line Extension Product Overview
- POWERWAVE
- POWERWAVE Product Overview
- RadiaDyne Endorectal Balloon Device
- RadiaDyne Endorectal Balloon Device Product Overview
- Smart Port - Dual
- Smart Port - Dual Product Overview
- Ultrasound-Assisted Thrombectomy System
- Ultrasound-Assisted Thrombectomy System Product Overview
- AngioDynamics Inc - Key Competitors
- AngioDynamics Inc - Key Employees
- AngioDynamics Inc - Key Employee Biographies
- AngioDynamics Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- AngioDynamics Inc, Recent Developments
- May 21, 2024: AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F1885 System
- May 06, 2024: AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
- May 03, 2024: Catheter-Directed Mechanical Thrombectomy System Demonstrates Safety and Effectiveness in Patients with Pulmonary Embolism
- Apr 16, 2024: AngioDynamics Receives Additional FDA 510(k) Clearance for AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
- Apr 04, 2024: Angiodynamics Receives 510(K) Clearance for Alphavac F1885 System in Treatment of PE
- Jan 23, 2024: AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
- Jan 05, 2024: AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
- Dec 07, 2023: AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism
- Aug 16, 2023: AngioDynamics’ AngioVac receives breakthrough device designation from FDA
- Aug 03, 2023: Angiodynamics Completes Enrollment for Preserve Clinical Study
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: AngioDynamics Inc Pipeline Products by Equipment Type
- Table 3: AngioDynamics Inc Pipeline Products by Indication
- Table 4: AngioDynamics Inc, Key Facts
- Table 5: AngioDynamics Inc, Major Products and Services
- Table 6: AngioDynamics Inc Number of Pipeline Products by Development Stage
- Table 7: AngioDynamics Inc Pipeline Products Summary by Development Stage
- Table 8: AngioDynamics Inc Ongoing Clinical Trials by Trial Status
- Table 9: AngioDynamics Inc Ongoing Clinical Trials Summary
- Table 10: Acuswift - Product Status
- Table 11: Acuswift - Product Description
- Table 12: Alphavac F13 10 - Product Status
- Table 13: Alphavac F13 10 - Product Description
- Table 14: Alphavac F14 20 - Product Status
- Table 15: Alphavac F14 20 - Product Description
- Table 16: Alphavac System - Infective Endocarditis - Product Status
- Table 17: Alphavac System - Infective Endocarditis - Product Description
- Table 18: Alphavac System - Left Atrial Appendage Thrombus - Product Status
- Table 19: Alphavac System - Left Atrial Appendage Thrombus - Product Description
- Table 20: AngioVac - Generation 4 - Product Status
- Table 21: AngioVac - Generation 4 - Product Description
- Table 22: AngioVac - Left Heart - Product Status
- Table 23: AngioVac - Left Heart - Product Description
- Table 24: AngioVac Low Profile Catheter - Product Status
- Table 25: AngioVac Low Profile Catheter - Product Description
- Table 26: AURYON Atherectomy System - CAD - Product Status
- Table 27: AURYON Atherectomy System - CAD - Product Description
- Table 28: AURYON Atherectomy System - Gastrointestinal Procedures - Product Status
- Table 29: AURYON Atherectomy System - Gastrointestinal Procedures - Product Description
- Table 30: AURYON Atherectomy System - Iliofemoral DVT - Product Status
- Table 31: AURYON Atherectomy System - Iliofemoral DVT - Product Description
- Table 32: AURYON Atherectomy System - Lead Extraction - Product Status
- Table 33: AURYON Atherectomy System - Lead Extraction - Product Description
- Table 34: AURYON Atherectomy System - Venous Disease - Product Status
- Table 35: AURYON Atherectomy System - Venous Disease - Product Description
- Table 36: AURYON System - Small Vessel Thrombectomy - Product Status
- Table 37: AURYON System - Small Vessel Thrombectomy - Product Description
- Table 38: Automated Fluid Management System - Product Status
- Table 39: Automated Fluid Management System - Product Description
- Table 40: BioFlo PICC Line Extension - Product Status
- Table 41: BioFlo PICC Line Extension - Product Description
- Table 42: BioFlo Portline Line Extension - Product Status
- Table 43: BioFlo Portline Line Extension - Product Description
- Table 44: Coronary Angio Catheter - Product Status
- Table 45: Coronary Angio Catheter - Product Description
- Table 46: FireFly Tip Location - Product Status
- Table 47: FireFly Tip Location - Product Description
- Table 48: Inflation Device - Product Status
- Table 49: Inflation Device - Product Description
- Table 50: Mechanical Thrombectomy Device - Product Status
- Table 51: Mechanical Thrombectomy Device - Product Description
- Table 52: Multi-Purpose Mechanical Aspiration - F1885 PE - Product Status
- Table 53: Multi-Purpose Mechanical Aspiration - F1885 PE - Product Description
- Table 54: Multi-Purpose Mechanical Aspiration Gen 2 - Product Status
- Table 55: Multi-Purpose Mechanical Aspiration Gen 2 - Product Description
- Table 56: NanoKnife 3.0 System - Liver Cancer - Product Status
- Table 57: NanoKnife 3.0 System - Liver Cancer - Product Description
- Table 58: NanoKnife 3.0 System - Pancreatic Cancer - Product Status
- Table 59: NanoKnife 3.0 System - Pancreatic Cancer - Product Description
- Table 60: NanoKnife 3.0 System - Prostate Cancer - Product Status
- Table 61: NanoKnife 3.0 System - Prostate Cancer - Product Description
- Table 62: Nanoknife System - Bladder Cancer - Product Status
- Table 63: Nanoknife System - Bladder Cancer - Product Description
- Table 64: NanoKnife System - Cervical Cancer - Product Status
- Table 65: NanoKnife System - Cervical Cancer - Product Description
- Table 66: NanoKnife System - Head And Neck Cancer - Product Status
- Table 67: NanoKnife System - Head And Neck Cancer - Product Description
- Table 68: NanoKnife System - Hepatocellular Carcinoma - Product Status
- Table 69: NanoKnife System - Hepatocellular Carcinoma - Product Description
- Table 70: NanoKnife System - Lung Cancer - Product Status
- Table 71: NanoKnife System - Lung Cancer - Product Description
- Table 72: NanoKnife System - Lung Cancer - A Novel Method for Treating Lung Metastases with the Combination of Electrical Fields and Radiation Therapy: A Single-arm Pilot Study
- Table 73: Nanoknife System - Metastatic Lymph Nodes - Product Status
- Table 74: Nanoknife System - Metastatic Lymph Nodes - Product Description
- Table 75: NanoKnife System - Prostate Cancer - Product Status
- Table 76: NanoKnife System - Prostate Cancer - Product Description
- Table 77: NanoKnife System - Prostate Cancer - A Pilot Study Evaluating Safety and Efficacy of Transperineal Focal Irreversible Electroporation (IRE) of Anterior Prostate Cancer in Patients with an Intermediate Risk
- Table 78: NanoKnife System - Prostate Cancer - Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-risk Patient Population
- Table 79: NanoKnife System - Prostate Cancer - Registry of Irreversible Electroporation for the Ablation of Prostate Cancer with Use of Nanoknife Device; A Multi-center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety
- Table 80: NanoKnife System - Rectal Cancer - Product Status
- Table 81: NanoKnife System - Rectal Cancer - Product Description
- Table 82: Nanoknife System - Renal Pelvis Urothelial Neoplasms - Product Status
- Table 83: Nanoknife System - Renal Pelvis Urothelial Neoplasms - Product Description
- Table 84: NanoKnife System - Stage III Pancreatic Cancer - Product Status
- Table 85: NanoKnife System - Stage III Pancreatic Cancer - Product Description
- Table 86: NanoKnife System - Stage III Pancreatic Cancer - A Phase 1 Study of Irreversible Electroporation and Pembrolizumab Immunotherapy in Locally Advanced Pancreatic Cancer
- Table 87: NanoKnife System - Stage III Pancreatic Cancer - A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma
- Table 88: NanoKnife System - Stage III Pancreatic Cancer - Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study
- Table 89: NanoKnife System - Stage III Pancreatic Cancer - Multicenter Clinical Trial of Widening the Applied Range of Steep Pulse (IRE)Therapy Instrument in Pancreatic Cancer
- Table 90: NanoKnife System - Stage III Pancreatic Cancer - Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
- Table 91: NanoKnife System - Stage III Pancreatic Cancer - Systemic Therapy with a Loco-regional Treatment in Patients with Locally Advanced Pancreatic Cancer: The SMART Study
- Table 92: Nanoknife System - Stomach Neoplasm - Product Status
- Table 93: Nanoknife System - Stomach Neoplasm - Product Description
- Table 94: Next Gen Tumescent Delivery Device - Product Status
- Table 95: Next Gen Tumescent Delivery Device - Product Description
- Table 96: Next Generation BioFlo PICC - Product Status
- Table 97: Next Generation BioFlo PICC - Product Description
- Table 98: Next Generation BioFlo Port - Product Status
- Table 99: Next Generation BioFlo Port - Product Description
- Table 100: Next Generation Dialysis Device - Product Status
- Table 101: Next Generation Dialysis Device - Product Description
- Table 102: Next Generation Laser - Product Status
- Table 103: Next Generation Laser - Product Description
- Table 104: Next Generation Radio Frequency Ablation System - Product Status
- Table 105: Next Generation Radio Frequency Ablation System - Product Description
- Table 106: Non-Thermal Vein Ablation Device - Product Status
- Table 107: Non-Thermal Vein Ablation Device - Product Description
- Table 108: Peripheral Vascular Drainage Line Extension - Product Status
- Table 109: Peripheral Vascular Drainage Line Extension - Product Description
- Table 110: POWERWAVE - Product Status
- Table 111: POWERWAVE - Product Description
- Table 112: RadiaDyne Endorectal Balloon Device - Product Status
- Table 113: RadiaDyne Endorectal Balloon Device - Product Description
- Table 114: Smart Port - Dual - Product Status
- Table 115: Smart Port - Dual - Product Description
- Table 116: Ultrasound-Assisted Thrombectomy System - Product Status
- Table 117: Ultrasound-Assisted Thrombectomy System - Product Description
- Table 118: AngioDynamics Inc, Key Employees
- Table 119: AngioDynamics Inc, Key Employee Biographies 7
- Table 120: AngioDynamics Inc, Other Locations
- Table 121: AngioDynamics Inc, Subsidiaries
- Table 122: Glossary
- List of Figures
- Figure 1: AngioDynamics Inc Pipeline Products by Equipment Type
- Figure 2: AngioDynamics Inc Pipeline Products by Development Stage
- Figure 3: AngioDynamics Inc Ongoing Clinical Trials by Trial Status
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.